We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Extraction Catheter Rapidly Removes Thrombus

By HospiMedica staff writers
Posted on 23 Aug 2006
A disposable extraction catheter combines a high level of deliverability and ease of use with rapid and reliable thrombus removal. More...


The QuickCat is a single use, disposable dual-lumen catheter for the removal of fresh soft emboli and thrombi from arterial blood vessels. The catheter is designed with a flexible, smooth, tapered distal end and an increasingly stiffer proximal end to allow for excellent pushability and atraumatic passage of the arterial system. The distal end of the catheter contains a hydrophilic coating and a 10-cm wire lumen for minimum drag and easy advancement through tortuous vessels. A radiopaque marker is placed approximately 1 mm from the tip.

The new catheter has a working length of 145 cm, has the lowest crossing profile (4.5F) of all current aspiration catheters, and is compatible with the smallest 6F guide catheters. Despite the lower profile, the catheter has high thrombus extraction efficiency. A uniform extraction lumen minimizes "bottle-necking,” resulting in a low incidence of clogging. The catheter has been approved by both the U.S. Food and Drug Administration (FDA) and the European Commission (EC).

The catheter is supplied with a vacuum assembly, which consists of an 18-cm extension tubing, one way stopcock, and a 30-ml vacuum syringe with an adjustable locking plunger. A 40-micron pore filter basket is provided to assist in filtering blood and thrombotic materials for analysis.

The QuickCat is made by Kensey Nash (Exton, PA, USA), and is expected to complement the company's ThromCat thrombectomy catheter system, a mechanical device that uses proprietary technology to remove more organized thrombi, currently under regulatory review in the European Union (EU).



Related Links:
Kensey Nash

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.